Both in Pharmaceuticals
Harrow vs Jade Biosciences
Over the past year HROW returned −26.5% and JBIO returned +46.9%; their daily moves had a correlation of 0.19.
HROW −26.5% JBIO +46.9%Growth of $1, one year, split-adjusted
| Metric | HROW | JBIO |
|---|---|---|
| Price | $26.04 | $14.10 |
| Market cap | $976.2M | $896.7M |
| Today | −9.43% | −6.25% |
| 1 month | −15.0% | +2.4% |
| 6 months | −33.3% | −41.8% |
| Year to date | −46.9% | −8.6% |
| 1 year | −26.3% | +56.7% |
| Revenue growth (YoY) | +10.9% | — |
| Gross margin | 71.3% | — |
| Net margin | −24.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.5× | — |
| Net cash | -$208.5M | $461.2M |
| Dividend yield | — | — |
| Volatility (60d) | 44.2% | 53.1% |
| Short % of float | 24.3% | 20.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).